Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine administered in a prime-boost regimen among Chinese infants: a randomized, double blind phase III clinical trial.

This study aimed to evaluate the immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine (PCV13). In total, 1200 infants were randomized into two groups with a 1:1 allocation and received a three-dose series of tested PCV13 or control PCV13 at ages 2, 4 and 6 months, respectively, and a booster dose at 12-15 months. Blood samples were collected before and 30 days after primary and booster vaccination.

Combustion synthesis and electrochemical properties of the small hydrofullerene C50H10.

The hydrofullerene C(50)H(10) is synthesized by low-pressure benzene-oxygen diffusion combustion. The structure of C(50)H(10) is identified through NMR, mass spectrometry, and IR and Raman spectroscopy as a D(5h) symmetric closed-cage molecule with five pairs of fused pentagons stabilized by ten hydrogen atoms. UV/Vis and fluorescence spectrometric analyses disclose its optical properties as comparable with those of its chloride cousin (C(50)Cl(10)).